newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates

BURLINGTON, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system